Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny E Blau

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Frontiers in Endocrinology|March 15, 2021
Familial HyperparathyroidismJenny E Blau, William F Simonds
Reviews in Endocrine & Metabolic Disorders|August 23, 2015
The PTH-Vitamin D-FGF23 axisJenny E Blau, Michael T Collins
Nature Reviews. Nephrology|June 8, 2018
Adverse effects of SGLT2 inhibitors on bone healthJenny E Blau, Simeon I Taylor
BMJ Case Reports|January 8, 2021
Acute oesophageal necrosis in multiple endocrine neoplasia type 1: an undescribed complicationSumona Bhattacharya, Jenny E Blau, Christopher Koh
Reviews in Endocrine & Metabolic Disorders|March 4, 2016
Understanding the metabolic and health effects of low-calorie sweeteners: methodological considerations and implications for future researchAllison C Sylvetsky, Jenny E Blau, Kristina I Rother
The Lancet. Diabetes & Endocrinology|December 20, 2014
Possible adverse effects of SGLT2 inhibitors on boneSimeon I Taylor, Jenny E Blau, Kristina I Rother
The Journal of Clinical Endocrinology and Metabolism|June 19, 2015
SGLT2 Inhibitors May Predispose to KetoacidosisSimeon I Taylor, Jenny E Blau, Kristina I Rother
Diabetes/Metabolism Research and Reviews|July 25, 2017
Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS dataJenny E Blau, Sri Harsha Tella, Simeon I Taylor, et al.
Hepatology Communications|May 23, 2024
The health care experience of adults with metabolic dysfunction-associated steatohepatitis and influence of PNPLA3: A qualitative studyJonathan G Stine, Nenad Medic, Billie Pettersson, et al.
The Lancet. Diabetes & Endocrinology|October 6, 2019
SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risksSimeon I Taylor, Jenny E Blau, Kristina I Rother, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Endocrinology|March 15, 2021
Familial HyperparathyroidismJenny E Blau, William F Simonds
Reviews in Endocrine & Metabolic Disorders|August 23, 2015
The PTH-Vitamin D-FGF23 axisJenny E Blau, Michael T Collins
Nature Reviews. Nephrology|June 8, 2018
Adverse effects of SGLT2 inhibitors on bone healthJenny E Blau, Simeon I Taylor
BMJ Case Reports|January 8, 2021
Acute oesophageal necrosis in multiple endocrine neoplasia type 1: an undescribed complicationSumona Bhattacharya, Jenny E Blau, Christopher Koh
Reviews in Endocrine & Metabolic Disorders|March 4, 2016
Understanding the metabolic and health effects of low-calorie sweeteners: methodological considerations and implications for future researchAllison C Sylvetsky, Jenny E Blau, Kristina I Rother
The Lancet. Diabetes & Endocrinology|December 20, 2014
Possible adverse effects of SGLT2 inhibitors on boneSimeon I Taylor, Jenny E Blau, Kristina I Rother
The Journal of Clinical Endocrinology and Metabolism|June 19, 2015
SGLT2 Inhibitors May Predispose to KetoacidosisSimeon I Taylor, Jenny E Blau, Kristina I Rother
Diabetes/Metabolism Research and Reviews|July 25, 2017
Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS dataJenny E Blau, Sri Harsha Tella, Simeon I Taylor, et al.
Hepatology Communications|May 23, 2024
The health care experience of adults with metabolic dysfunction-associated steatohepatitis and influence of PNPLA3: A qualitative studyJonathan G Stine, Nenad Medic, Billie Pettersson, et al.
The Lancet. Diabetes & Endocrinology|October 6, 2019
SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risksSimeon I Taylor, Jenny E Blau, Kristina I Rother, et al.
Pageof 5